This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-001152-v6uc0ijw | Is RNA interference involved in intrinsic antiviral immunity in mammals? |
| cord-001527-x8yswoua | observations from household- based trials Estimating influenza vaccine efficacy from challenge and community- based study data Containing the accidental laboratory escape of potential pandemic influenza viruses Predicting"airborne"influenza viruses:( trans-) mission impossible? |
| cord-003143-n6b0r92e | Two years after pandemic influenza A/2009/ H1N1: what have we learned? |
| cord-274396-l611eisi | ␣ of Middle East respiratory syndrome Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen Antimalarial drug chloroquine counteracts activation of indoleamine( 2,3)-dioxygenase activity in human PBMC Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS- CoV-2 infection in vitro Hydroxychloroquine for SARS- CoV-2 infection: how did we get here? |
| cord-305698-fjd0rsrf | Will the NSABB and the Academies be nimble enough to make concrete recommendations that are broadly acceptable within months? |
| cord-298773-vnmc6nqd | : cord-298773-vnmc6nqd authors: Pfeiffer, Julie K. title: Is the Debate and “ Pause ” on Experiments That Alter Pathogens with Pandemic Potential Influencing Future Plans of Graduate Students and Postdoctoral Fellows? |
| cord-298773-vnmc6nqd | For example, factoring in retirement rates and potential loss of future investigators, what will the influenza/ MERS/ SARS virus fields look like in 2030, 2040, or 2050? |
| cord-281389-sht0yx4a | Why would the host dampen its immune response to infection? |
| cord-274663-zyzgk2z3 | Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs TDP-43: multiple targets, multiple disease mechanisms? |
| cord-308848-chvvtr0d | Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection? |
| cord-334463-nvu5tqxb | The poliovirus receptor: a hook, or an unzipper? |
| cord-012487-s920s5wb | ( PlsB) Regulation of phospholipid synthesis in Escherichia coli by guanosine tetraphosphate Regulation of membrane phospholipid synthesis by the relA gene: dependence on ppGpp levels Effect of ppGpp on Escherichia coli cyclopropane fatty acid synthesis is mediated through the RpoS sigma factor( sigmaS) Enzymology, genetics, and regulation of membrane phospholipid synthesis in Escherichia coli Bacterial membrane lipids: where do we stand? |
| cord-012487-s920s5wb | But what controls PlsB? |
| cord-012487-s920s5wb | What might have caused the transient increase in fatty acid synthesis observed after translation inhibition? |
| cord-286587-x0wqtlxh | Could they discover a treatment that might reduce the severity of COVID-19 infection and improve patient survival? |
| cord-286587-x0wqtlxh | Do viral infections mimic bacterial sepsis? |
| cord-286587-x0wqtlxh | Yet, for those who develop severe disease, only one question matters:"will I live or die? |
| cord-296028-hqrd1e8p | An epistemological perspective on the value of gain- of- function experiments involving pathogens with pandemic potential Can limited scientific value of potential pandemic pathogen experiments justify the risks? |
| cord-296028-hqrd1e8p | sciences Promoting inherent safety Are we too risk- averse for inherent safety? |
| cord-264050-6zpw6itb | What is a host? |
| cord-330315-upcf15q5 | Do viruses subvert cholesterol homeostasis to induce host cubic membranes? |
| cord-287892-bnqmwst8 | Enterovirus protein 2B po(u)res out the calcium: a viral strategy to survive? |
| cord-263357-krvei97r | How does the genomic analysis of HCoV- EMC expedite further research on this new human virus? |
| cord-263357-krvei97r | What can analysis of its RNA genome tell us about this new human coronavirus? |
| cord-263357-krvei97r | What features of the genome and its translational strategy are similar to or different from those of other coronaviruses? |
| cord-263357-krvei97r | What is the relationship between HCoV- EMC and known coronaviruses? |
| cord-263357-krvei97r | What questions must be answered to show whether HCoV- EMC is likely to cause an epidemic or adapt to become endemic in humans? |
| cord-353612-9ux181xg | Experimental%20Metadata/ HCoV- EMC%20 infection%20in%20Calu-3%20cells/ begin.view?. |
| cord-353612-9ux181xg | The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogen- activated protein kinase p38-dependent tyrosine kinase activity during virus infection Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/ p38 MAP kinase Mitogen activated protein kinase inhibitors: where are we now and where are we going? |
| cord-352096-cc3dzycl | The innate immune system: fighting on the front lines or fanning the flames of COVID-19? |
| cord-324978-9qfhsj3n | Did MERS- CoV truly emerge as a human pathogen in 2012, or were cases of cryptic infection not appreciated because of a lack of suitable diagnostic tests? |
| cord-324978-9qfhsj3n | What are the roles of bats, if any, as reservoirs of MERS- CoV? |
| cord-331361-pd9lt4n2 | : why are they so deadly? |
| cord-331361-pd9lt4n2 | Human T- cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans Heparan sulphate proteoglycans and viral vectors: ally or foe? |
| cord-331361-pd9lt4n2 | Nipah virus- a potential agent of bioterrorism? |
| cord-290297-efo9f7c5 | First, are there synergic interactions between the SARS- CoV-2 virus and certain coinfecting bacteria? |
| cord-290297-efo9f7c5 | Second, does coinfection with antibiotic- resistant bacteria affect disease severity? |
| cord-001672-7lh8iqm1 | Does it give us elapsed time for a 50% chance, or an 80% chance? |
| cord-001672-7lh8iqm1 | Does it give us the elapsed time for a 10% chance that an LAI occurs? |
| cord-289360-h6wvx7gw | A strategy to estimate unknown viral diversity in mammals Is the debate and"pause"on experiments that alter pathogens with pandemic potential influencing future plans of graduate students and postdoctoral fellows? |
| cord-289360-h6wvx7gw | mBio Is virology dead? |
| cord-256550-72i1x02f | Is an E of 0.1%, 1%, or 10% too high? |
| cord-256550-72i1x02f | Is it really acceptable for a manufacturing company to dump mercury in the ocean, because that one factory's output would not be enough to pose any danger to us when we consume fish? |
| cord-256550-72i1x02f | Is there nothing wrong if I buy a gas guzzler that gets 10 miles per gallon and has faulty emissions control, since my car's individual contribution to climate destruction is minimal? |
| cord-256550-72i1x02f | The first question to be asked is"what is the probability of at least one escape from one of the n labs conducting research on the pathogen for y years?" |
| cord-256550-72i1x02f | What if everyone researched live smallpox?"has been implicitly answered according to Kant's categorical imperative by everyone agreeing to limit research to two places. |
| cord-335432-9aszklx3 | Must a name mean something? |
| cord-335432-9aszklx3 | At this juncture, it is reasonable to ask,"is it possible to extract ourselves from this rabbit hole? |
| cord-335432-9aszklx3 | Does the name aTRIP help, or does it just add more complexity to this muddle? |
| cord-335432-9aszklx3 | How did we find ourselves in this lexiconic morass? |
| cord-335432-9aszklx3 | What does it mean?" |
| cord-335432-9aszklx3 | When Humpty met Alice, he asked the intrepid adventurer"tell me your name and your business?" |
| cord-287487-qeltdch7 | Can MHV replicase proteins mediate high- fidelity replication without ExoN proofreading? |
| cord-287487-qeltdch7 | Can MHV replicase proteins mediate high- fidelity replication without ExoN proofreading? |
| cord-287487-qeltdch7 | In the face of selective pressure for increased fidelity, why did MHV- ExoN(-) not revert? |
| cord-287487-qeltdch7 | The role of mutational robustness in RNA virus evolution Plaques formed by mutagenized viral populations have elevated coinfection frequencies Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis Does mutational robustness inhibit extinction by lethal mutagenesis in viral populations? |
| cord-287487-qeltdch7 | Which mechanisms other than increased fidelity can compensate for the loss of proofreading? |
| cord-287487-qeltdch7 | Which mechanisms other than increased fidelity might account for MHV- ExoN(-) P250 nucleoside analog resistance? |
| cord-287487-qeltdch7 | hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus Mouse hepatitis virus S RNA sequence reveals that nonstructural proteins ns4 and ns5a are not essential for murine coronavirus replication Luxury at a cost? |
| cord-287487-qeltdch7 | not revert? |
| cord-287487-qeltdch7 | nsp10 is a critical regulator of viral RNA synthesis Ribavirin's antiviral mechanism of action: lethal mutagenesis? |